Tyra Biosciences Ownership | Who Owns Tyra Biosciences?


OverviewForecastRevenueFinancialsChart

Tyra Biosciences Ownership Summary


Tyra Biosciences is owned by 89.63% institutional investors, 4.86% insiders, and 5.51% retail investors. Ra capital management is the largest institutional shareholder, holding 19.94% of TYRA shares. Fidelity Series Small Cap Opps is the top mutual fund, with 1.38% of its assets in Tyra Biosciences shares.

TYRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTyra Biosciences89.63%4.86%5.51%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management10.42M19.94%$166.56M
Boxer capital6.45M12.35%$103.11M
Bvf inc/il4.66M8.92%$74.53M
Canaan partners xi4.41M8.44%$70.52M
Nextech invest4.06M7.77%$64.85M
Fmr3.35M6.41%$53.51M
Tcg crossover management1.99M3.81%$31.81M
Blackrock1.42M2.72%$22.69M
Vanguard group1.24M2.37%$19.80M
Perceptive advisors1.01M1.93%$16.11M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Canaan partners xi4.41M85.38%$70.52M
Nextech invest4.06M10.91%$64.85M
Boxer capital6.45M5.43%$103.11M
5am venture management939.30K3.36%$15.02M
Tcg crossover management1.99M3.31%$31.81M
Sio capital management600.29K2.60%$9.60M
Ally bridge group (ny)264.66K2.52%$4.23M
Ra capital management10.42M2.20%$166.56M
Bvf inc/il4.66M2.09%$74.53M
Kynam capital management, lp566.72K0.70%$9.06M

Top Buyers

HolderShares% AssetsChange
Blackrock1.42M0.00%374.63K
Vanguard group1.24M0.00%338.70K
Perceptive advisors1.01M0.38%338.21K
Ally bridge group (ny)264.66K2.52%264.66K
Ensign peak advisors190.56K0.01%190.56K

Top Sellers

HolderShares% AssetsChange
Fairmount funds management---1.39M
Fmr3.35M0.00%-630.54K
First turn management---381.21K
Avidity partners management lp---373.00K
Driehaus capital management---203.71K

New Positions

HolderShares% AssetsChangeValue
Ally bridge group (ny)264.66K2.52%264.66K$4.23M
Ensign peak advisors190.56K0.01%190.56K$3.05M
Jennison associates149.35K0.00%149.35K$2.39M
Woodline partners lp88.66K0.01%88.66K$1.42M
Tang capital management42.22K0.07%42.22K$675.15K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
Simplex trading-100.00
Adar1 capital management-300.00
Ikarian capital-501.00
Metropolitan life insurance co/ny-814.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202476-2.56%46,814,707-0.08%891.11%472.17%15-6.25%
Mar 31, 20247821.88%46,852,11731.03%891.28%4643.75%1633.33%
Dec 31, 2023648.47%35,756,693-1.94%831.16%3260.00%12-25.00%
Sep 30, 202359-36,462,6330.70%851.18%20-28.57%1614.29%
Jun 30, 20235913.46%36,210,8091.53%851.20%28-1455.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Series Small Cap Opps726.38K1.38%-31.50K
Vanguard Total Stock Mkt Idx Inv724.09K1.37%-
Fidelity Small Cap Growth641.40K1.21%-2.88K
iShares Russell 2000 ETF531.35K1.00%-1.19K
Fidelity Stock Selector Small Cap493.15K0.93%10.70K
Fidelity Advisor Biotechnology I390.89K0.74%-
Biotech Growth Ord384.32K0.73%-
Vanguard Institutional Extnd Mkt Idx Tr332.89K0.63%-11.59K
Fidelity Small Cap Growth K6249.61K0.47%4.26K
Fidelity Select Biotechnology215.80K0.41%24.40K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 08, 2024RA CAPITAL MANAGEMENT, L.P. Buy$19.84M
Nov 07, 2024Kjellson Nina S-Sell$41.06K
Nov 06, 2024Kjellson Nina S-Sell$804.78K
Nov 07, 2024Kjellson Nina S-Sell$341.51K
Nov 06, 2024Kjellson Nina S-Sell$96.78K

Insider Transactions Trends


DateBuySell
2024 Q4125
2024 Q3-8
2024 Q2-2
2024 Q1-17
2023 Q3-9

TYRA Ownership FAQ


Who Owns Tyra Biosciences?

Tyra Biosciences shareholders are primarily institutional investors at 89.63%, followed by 4.86% insiders and 5.51% retail investors. The average institutional ownership in Tyra Biosciences's industry, Biotech Stocks , is 44.97%, which Tyra Biosciences exceeds.

Who owns the most shares of Tyra Biosciences?

Tyra Biosciences’s largest shareholders are Ra capital management (10.42M shares, 19.94%), Boxer capital (6.45M shares, 12.35%), and Bvf inc/il (4.66M shares, 8.92%). Together, they hold 41.21% of Tyra Biosciences’s total shares outstanding.

Does Blackrock own Tyra Biosciences?

Yes, BlackRock owns 2.72% of Tyra Biosciences, totaling 1.42M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.69M$. In the last quarter, BlackRock increased its holdings by 374.63K shares, a 35.88% change.

Who is Tyra Biosciences’s biggest shareholder by percentage of total assets invested?

Canaan partners xi is Tyra Biosciences’s biggest shareholder by percentage of total assets invested, with 85.38% of its assets in 4.41M Tyra Biosciences shares, valued at 70.52M$.

Who is the top mutual fund holder of Tyra Biosciences shares?

Fidelity Series Small Cap Opps is the top mutual fund holder of Tyra Biosciences shares, with 1.38% of its total shares outstanding invested in 726.38K Tyra Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools